Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hicklin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Praxis|February 7, 2019
[Shift Work and Sleep]Daniel Hicklin, Jürg Schwander
Leukemia & Lymphoma|June 30, 2004
Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2Haifan Zhang, Yiwen Li, Hongli Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenograftsGiannoula Klement, Ping Huang, Barbara Mayer, et al.
Cancer Research|January 20, 2007
Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growthPirjo Laakkonen, Marika Waltari, Tanja Holopainen, et al.
Blood|April 22, 2004
Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasiaRainer Kunstfeld, Satoshi Hirakawa, Young-Kwon Hong, et al.
Nature|December 13, 2005
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic nicheRosandra N Kaplan, Rebecca D Riba, Stergios Zacharoulis, et al.
Cancer Discovery|April 26, 2013
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitorsErick J Morris, Sharda Jha, Clifford R Restaino, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Praxis|February 7, 2019
[Shift Work and Sleep]Daniel Hicklin, Jürg Schwander
Leukemia & Lymphoma|June 30, 2004
Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2Haifan Zhang, Yiwen Li, Hongli Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenograftsGiannoula Klement, Ping Huang, Barbara Mayer, et al.
Cancer Research|January 20, 2007
Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growthPirjo Laakkonen, Marika Waltari, Tanja Holopainen, et al.
Blood|April 22, 2004
Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasiaRainer Kunstfeld, Satoshi Hirakawa, Young-Kwon Hong, et al.
Nature|December 13, 2005
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic nicheRosandra N Kaplan, Rebecca D Riba, Stergios Zacharoulis, et al.
Cancer Discovery|April 26, 2013
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitorsErick J Morris, Sharda Jha, Clifford R Restaino, et al.
Pageof 1